Advertisement

TTNP

Titan Pharmaceuticals, Inc.

Healthcare

Set alert

Price alert · TTNP

All alert types
2.34 0.00 0.00%
As of Dec 16, 2025
2.30 Day range 2.69
3.14 52-week range 14.80
YTD
-28.22%
1 year
-55.09%
Open
2.55
Prev close
2.34
Mkt cap
2.96M
Vol
131.90K
Avg vol
18.01K
EPS
-6.64
P/E
0.00
Div yield
0.00%
More statistics
Low
2.30
High
2.69
Forward P/E
-3.56
Beta
1.13
Short ratio
0.66
Inst. own
1.85%
Dividend
0.00
Ex-div date
Earnings
Dec 24, 2024
50-d avg
3.97
200-d avg
5.73
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for TTNP has not been loaded yet. Try again in a moment.

Ownership

Held by insiders 45.47%
Held by institutions 1.85%
Float held by institutions 3.40%
Institutions 16

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Renaissance Technologies, LLC1.21%11,06635.85KSep 29, 2024
UBS Group AG0.52%4,77315.46KSep 29, 2024
Tower Research Capital LLC (TRC)0.08%7432.41KSep 29, 2024
MCF Advisors LLC0.02%165534Sep 29, 2024
Global Wealth Strategies & Associates 0.00%26Sep 29, 2024
Osaic Holdings Inc0.00%1032Sep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.45%4,10313.29KSep 29, 2024
Fidelity Extended Market Index Fund0.34%3,14610.19KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.11%9633.12KOct 30, 2024
Fidelity Series Total Market Index Fund0.10%9543.09KOct 30, 2024
TTNP insiders
InsiderRelationLatest transactionDateShares held
BEN-TZVI AVRAHAMDirectorStock Award(Grant)Oct 24, 202366,250
CHASEY PETER LOUISDirectorStock Award(Grant)Jul 25, 202350,000
CHOONG CHOON HAUBeneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityMar 17, 20243,802,100
GREENBERG ERIC HOWARDDirectorStock Award(Grant)Oct 24, 202366,250
LAZAR DAVID ELLIOTChief Executive OfficerStock Award(Grant)Jul 25, 2023100,000
MCMURDO MATTHEW CHARLESDirectorStock Award(Grant)Oct 24, 202366,250
Advertisement